Pipeline Products
ScinoPharm selects target products based on customers’ potential interests and next-generation blockbuster drugs in each therapeutic area. Our primary objectives are to align with future customer needs and serve as the leading API supplier to First-to-File ANDA holders, positioning us as a reliable and trusted partner.
| Small molecules | ||
| API Name | Therapeutic Area | Production Site |
| Alectinib HCl | Oncology | Taiwan |
| Capivasertib | Oncology | Taiwan |
| Fezolinetant | Women's Health | China |
| Orforglipron Calcium | Metabolic | Taiwan |
| Xanomeline | CNS | China |
| Zanubrutinib Form A | Oncology | China |
| Peptide Drugs -Solid Synthesis | ||
| API Name | Therapeutic Area | Production Site |
| Semaglutide | Metabolic | Taiwan |
| Tirzepatide | Metabolic | Taiwan |
__25J14XhUoe.png)
